Published on 7 Feb 2024 on Pharmaceutical Executive Magazine
The agreement, which is still subject to closing conditions, says that Novartis will pay about $73-per-share (68 Euros-per-share), for a total of $2.9...
Start tracking your investments with Statfolio
Artificial intelligence has been a hot area of investment for so long now that it's virtually...
Novartis AG (SIX:NOVN) (NYSE: NVS), a global healthcare company, has reported a solid third-quart...
On Tuesday, Novartis AG (NYSE:NVS) reported third-quarter sales of $12.823 billion, up 9% (+10% o...
*Stock Advisor returns as of October 28, 2024 Vasant Narasimhan -- Chief Executive... Kirsch on t...
, opens new tab raised its 2024 earnings guidance for the third time on Tuesday, buoyed by wider ...
Monte Rosa Therapeutics Inc (NASDAQ:GLUE) stock is trading higher on Monday after the company...
We recently published a list of 10 Wonderful Stocks to Buy Now at a Fair Price. In this article, ...
We recently compiled a list of the 10 Best Cancer Stocks To Buy Now. In this article, we are goin...
We recently compiled a list of the Top 10 Stocks on Jim Cramer’s Radar. In this article, we are...